Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis

  • Authors:
    • Lingchen Kong
    • Peng Wu
    • Jianzhong Li
  • View Affiliations / Copyright

    Affiliations: Department of Critical Care Medicine, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China
    Copyright: © Kong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1343-1352
    |
    Published online on: June 10, 2020
       https://doi.org/10.3892/etm.2020.8854
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to determine the expression level of claudin‑2 (CLDN2) in the peripheral blood of patients with sepsis, and to investigate its potential function and mechanism of action in vascular endothelial injury. A total of 25 patients with sepsis were included in the present study. Reverse transcription‑quantitative PCR was used to determine CLDN2 levels in peripheral blood. HUVECs stably expressing CLDN2 were prepared and Cell Counting Kit‑8, flow cytometry and Transwell assays were performed to study the proliferation, apoptosis and migration of HUVECs, respectively. Using bioinformatics, microRNA (miR) molecules that interact with CLDN2 were predicted. A dual luciferase reporter assay was used to test whether miR‑331 regulated CLDN2. Western blotting was employed to determine CLDN2 protein expression. In addition, in vitro transfection of HUVECs with miR‑331 mimics was performed to test the rescue effects of miR‑331 on the cell function changes induced by CLDN2. The results indicated that elevated CLDN2 expression altered the proliferation and cell cycle of peripheral vascular endothelial cells. CLDN2 overexpression inhibited HUVEC proliferation via mechanisms not associated with the cell cycle. CLDN2 mRNA levels in the peripheral blood of patients with sepsis were significantly higher than those in healthy subjects. Upregulated CLDN2 expression promoted the apoptosis of HUVECs, but reduced their proliferation and migration. Notably, miR‑331 was able to bind with CLDN2 mRNA and regulate its expression. Upregulation of miR‑331 expression inhibited the expression of CLDN2 and restored nearly normal proliferation, apoptosis and migration to HUVECs. The present study demonstrated that CLDN2 expression is elevated in peripheral blood from patients with sepsis, and promotes the injury of vascular endothelial cells. In addition, miR‑331 participates in the direct regulation of CLDN2, and upregulation of miR‑331 expression inhibits the expression of CLDN2 and restores cellular functions to HUVECs.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Rhee C and Klompas M: Sepsis trends: Increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 12 (Suppl 1):S89–S100. 2020.PubMed/NCBI View Article : Google Scholar

2 

Kuchler L, Sha LK, Giegerich AK, Knape T, Angioni C, Ferreirós N, Schmidt MV, Weigert A, Brüne B and von Knethen A: Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis. Mol Immunol. 90:255–263. 2017.PubMed/NCBI View Article : Google Scholar

3 

Chao CH, Chen HR, Chuang YC and Yeh TM: Macrophage migration inhibitory factor-induced autophagy contributes to thrombin-triggered endothelial hyperpermeability in sepsis. Shock. 50:103–111. 2018.PubMed/NCBI View Article : Google Scholar

4 

Bobelytė O, Gailiūtė I, Zubka V and Žilinskaitė V: Sepsis epidemiology and outcome in the paediatric intensive care unit of Vilnius University Children's Hospital. Acta Med Litu. 24:113–120. 2017.PubMed/NCBI View Article : Google Scholar

5 

Malik IA, Cardenas-Turanzas M, Gaeta S, Borthakur G, Price K, Cortes J and Nates JL: Sepsis and acute myeloid leukemia: A population-level study of comparative outcomes of patients discharged from Texas hospitals. Clin Lymphoma Myeloma Leuk. 17:e27–e32. 2017.PubMed/NCBI View Article : Google Scholar

6 

Dombrovskiy VY, Martin AA, Sunderram J and Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 35:1244–1250. 2007.PubMed/NCBI View Article : Google Scholar

7 

Raju R: Immune and metabolic alterations following trauma and sepsis - An overview. Biochim Biophys Acta Mol Basis Dis. 1863:2523–2525. 2017.PubMed/NCBI View Article : Google Scholar

8 

Katayama S, Nunomiya S, Koyama K, Wada M, Koinuma T, Goto Y, Tonai K and Shima J: Markers of acute kidney injury in patients with sepsis: The role of soluble thrombomodulin. Crit Care. 21(229)2017.PubMed/NCBI View Article : Google Scholar

9 

Sergi C, Shen F, Lim DW, Liu W, Zhang M, Chiu B, Anand V and Sun Z: Cardiovascular dysfunction in sepsis at the dawn of emerging mediators. Biomed Pharmacother. 95:153–160. 2017.PubMed/NCBI View Article : Google Scholar

10 

Schaalan M and Mohamed W: Predictive ability of circulating osteoprotegerin as a novel biomarker for early detection of acute kidney injury induced by sepsis. Eur Cytokine Netw. 28:52–62. 2017.PubMed/NCBI View Article : Google Scholar

11 

Rieg S, Bechet L, Naujoks K, Hromek J, Lange B, Juzek-Küpper MF, Stete K, Müller MC, Jost I, Kern WV, et al: A single-center prospective cohort study on postsplenectomy sepsis and its prevention. Open Forum Infect Dis. 7(ofaa050)2020.PubMed/NCBI View Article : Google Scholar

12 

Pluskota E, Bledzka KM, Bialkowska K, Szpak D, Soloviev DA, Jones SV, Verbovetskiy D, Plow EF, et al: Kindlin-2 interacts with endothelial adherens junctions to support vascular barrier integrity. J Physiol. 595:6443–6462. 2017.PubMed/NCBI View Article : Google Scholar

13 

Sun K, Lei Y, Wang R, Wu Z and Wu G: Cinnamicaldehyde regulates the expression of tight junction proteins and amino acid transporters in intestinal porcine epithelial cells. J Anim Sci Biotechnol. 8(66)2017.PubMed/NCBI View Article : Google Scholar

14 

Thuringer D, Solary E and Garrido C: The microvascular gap junction channel: A route to deliver MicroRNAs for neurological disease treatment. Front Mol Neurosci. 10(246)2017.PubMed/NCBI View Article : Google Scholar

15 

Li X, Song G, Zhao Y, Zhao F, Liu C, Liu D, Li Q and Cui Z: Claudin7b is required for the formation and function of inner ear in zebrafish. J Cell Physiol. 233:3195–3206. 2018.PubMed/NCBI View Article : Google Scholar

16 

Kolosov D, Bui P, Wilkie MP and Kelly SP: Claudins of sea lamprey (Petromyzon marinus) - organ-specific expression and transcriptional responses to water of varying ion content. J Fish Biol. 96:768–781. 2020.PubMed/NCBI View Article : Google Scholar

17 

Taylor NA, Vick SC, Iglesia MD, Brickey WJ, Midkiff BR, McKinnon KP, Reisdorf S, Anders CK, Carey LA, Parker JS, et al: Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer. J Clin Invest. 127:3472–3483. 2017.PubMed/NCBI View Article : Google Scholar

18 

Chung YH, Li SC, Kao YH, Luo HL, Cheng YT, Lin PR, Tai MH and Chiang PH: MiR-30a-5p inhibits epithelial-to-mesenchymal transition and upregulates expression of tight junction protein claudin-5 in human upper tract urothelial carcinoma cells. Int J Mol Sci. 18(18)2017.PubMed/NCBI View Article : Google Scholar

19 

Ahmad R, Kumar B, Chen Z, Chen X, Müller D, Lele SM, Washington MK, Batra SK, Dhawan P and Singh AB: Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Oncogene. 36:6592–6604. 2017.PubMed/NCBI View Article : Google Scholar

20 

Hashimoto Y, Shirakura K, Okada Y, Takeda H, Endo K, Tamura M, Watari A, Sadamura Y, Sawasaki T, Doi T, et al: Claudin-5-binders enhance permeation of solutes across the blood-brain barrier in a mammalian model. J Pharmacol Exp Ther. 363:275–283. 2017.PubMed/NCBI View Article : Google Scholar

21 

Tesfaye D, Gebremedhn S, Salilew-Wondim D, Hailay T, Hoelker M, Grosse-Brinkhaus C and Schellander K: MicroRNAs: tiny molecules with significant role in mammalian follicular and oocyte development. Reproduction. 155:R121–R135. 2018.PubMed/NCBI View Article : Google Scholar

22 

Song L, Li D, Li X, Ma L, Bai X, Wen Z, Zhang X, Chen D and Peng L: Exposure to PM2.5 induces aberrant activation of NF-κB in human airway epithelial cells by downregulating miR-331 expression. Environ Toxicol Pharmacol. 50:192–199. 2017.PubMed/NCBI View Article : Google Scholar

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) μethod. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

24 

Mao FY, Kong H, Zhao YL, Peng LS, Chen W, Zhang JY, Cheng P, Wang TT, Lv YP, Teng YS, et al: Increased tumor-infiltrating CD45RA-CCR7- regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress. Cell Death Dis. 8(e3002)2017.PubMed/NCBI View Article : Google Scholar

25 

Peng LS, Zhang JY, Teng YS, Zhao YL, Wang TT, Mao FY, Lv YP, Cheng P, Li WH, Chen N, et al: Tumor-associated monocytes/macrophages impair NK-cell function via TGFβ1 in human gastric cancer. Cancer Immunol Res. 5:248–256. 2017.PubMed/NCBI View Article : Google Scholar

26 

Kam HJ and Kim HY: Learning representations for the early detection of sepsis with deep neural networks. Comput Biol Med. 89:248–255. 2017.PubMed/NCBI View Article : Google Scholar

27 

Tham CL, Hazeera Harith H, Wai Lam K, Joong Chong Y, Singh Cheema M, Roslan Sulaiman M, Hj Lajis N and Ahmad Israf D: The synthetic curcuminoid BHMC restores endotoxin-stimulated HUVEC dysfunction: Specific disruption on enzymatic activity of p38 MAPK. Eur J Pharmacol. 749:1–11. 2015.PubMed/NCBI View Article : Google Scholar

28 

Sumitomo T: Streptococcus pyogenes translocates across an epithelial barrier. Nippon Saikingaku Zasshi. 72:213–218. 2017.PubMed/NCBI View Article : Google Scholar : (Ιn Japanese).

29 

Rosas-Hernandez H, Cuevas E, Escudero-Lourdes C, Lantz SM, Gomez-Crisostomo NP, Sturdivant NM, Balachandran K, Imam SZ, Slikker W Jr, Paule MG, et al: Characterization of Biaxial stretch as an in vitro model of traumatic brain injury to the blood-brain barrier. Mol Neurobiol. 55:258–266. 2018.PubMed/NCBI View Article : Google Scholar

30 

Fujii N, Matsuo Y, Matsunaga T, Endo S, Sakai H, Yamaguchi M, Yamazaki Y, Sugatani J and Ikari A: Hypotonic stress-induced down-regulation of claudin-1 and -2 mediated by dephosphorylation and clathrin-dependent endocytosis in renal tubular epithelial cells. J Biol Chem. 291:24787–24799. 2016.

31 

Tan X, Li D, Wang X, Zeng Y, Yan Y and Yang L: Claudin-2 downregulation by KSHV infection is involved in the regulation of endothelial barrier function. J Cutan Pathol. 41:630–639. 2014.PubMed/NCBI View Article : Google Scholar

32 

Du W, Xu X, Niu Q, Zhang X, Wei Y, Wang Z, Zhang W, Yan J, Ru Y, Fu Z, et al: Spi-B-mediated silencing of claudin-2 promotes early dissemination of lung cancer cells from primary tumors. Cancer Res. 77:4809–4822. 2017.PubMed/NCBI View Article : Google Scholar

33 

Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N and Xu B: A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. PLoS One. 9(e112765)2014.PubMed/NCBI View Article : Google Scholar

34 

Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M and Richter P: Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: The importance of miR-21 and miR-331. Br J Cancer. 117:266–273. 2017.PubMed/NCBI View Article : Google Scholar

35 

Butrym A, Rybka J, Baczyńska D, Tukiendorf A, Kuliczkowski K and Mazur G: Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients. Biomarkers Med. 9:453–460. 2015.PubMed/NCBI View Article : Google Scholar

36 

Hosako H, Martin GS, Barrier M, Chen YA, Ivanov IV and Mirkes PE: Gene and microRNA expression in p53-deficient day 8.5 mouse embryos. Birth Defects Res A Clin Mol Teratol. 85:546–555. 2009.PubMed/NCBI View Article : Google Scholar

37 

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A and Tang H: Upregulated in hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget. 6:38093–38106. 2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kong L, Wu P and Li J: miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis. Exp Ther Med 20: 1343-1352, 2020.
APA
Kong, L., Wu, P., & Li, J. (2020). miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis. Experimental and Therapeutic Medicine, 20, 1343-1352. https://doi.org/10.3892/etm.2020.8854
MLA
Kong, L., Wu, P., Li, J."miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis". Experimental and Therapeutic Medicine 20.2 (2020): 1343-1352.
Chicago
Kong, L., Wu, P., Li, J."miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1343-1352. https://doi.org/10.3892/etm.2020.8854
Copy and paste a formatted citation
x
Spandidos Publications style
Kong L, Wu P and Li J: miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis. Exp Ther Med 20: 1343-1352, 2020.
APA
Kong, L., Wu, P., & Li, J. (2020). miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis. Experimental and Therapeutic Medicine, 20, 1343-1352. https://doi.org/10.3892/etm.2020.8854
MLA
Kong, L., Wu, P., Li, J."miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis". Experimental and Therapeutic Medicine 20.2 (2020): 1343-1352.
Chicago
Kong, L., Wu, P., Li, J."miR-331 inhibits CLDN2 expression and may alleviate the vascular endothelial injury induced by sepsis". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1343-1352. https://doi.org/10.3892/etm.2020.8854
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team